We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

By LabMedica International staff writers
Posted on 02 Oct 2025

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. More...

The use of PCR during the COVID-19 pandemic showed its value, but traditional systems often require significant time, specialized staff, and costly infrastructure. There is a growing need for solutions that reduce testing time, automate processes, and increase efficiency across multiple test items. Now, a new partnership to jointly develop a fully automated PCR testing system aims to address these challenges.

ELITechGroup (Puteaux, France), a Bruker company, and Hitachi High-Tech Corporation (Tokyo, Japan) have been jointly developing a fully automated molecular testing system that can detect viruses and bacteria at an early stage. The companies have now entered into a collaboration, manufacturing, and supply agreement in the field of molecular testing for infectious diseases.

Hitachi High-Tech has development and technical capabilities, such as photometric analysis and automation, which are utilized for its life sciences and in vitro diagnostics products. ELITech offers fully automated PCR testing systems and reagents for the European market, with a particular strength in reagents for a wide range of test items.

Their joint development efforts will focus on creating an innovative and flexible PCR platform that enhances operational efficiency in microbiology and virology laboratories, ultimately contributing to improved patient care. The PCR testing system offers continuous sample and reagent loading as well as random-access capabilities in accordance with the needs of the laboratory, together with fully automated functions from sample preparation to measurement.

This agreement governs Hitachi High-Tech’s supply of the system to ELITech. Going forward, Hitachi High-Tech will continue to foster innovation in the area of infectious diseases with ELITech, and through this partnership and others, we will build strong and long-term relationships with its partners.


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
Rapid Molecular Testing Device
FlashDetect Flash10
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.